Pharma Journalist -

SMi Reports: Event Announcement: Pre-Filled Syringes and Injectable Drug Devices, January 12-13th January 2021 is now a virtual event. Access will be fully online meaning therefore…
Read More...

Evotec SE announced that the Company has received a US$ 18 m grant from the Bill & Melinda Gates Foundation (Seattle, WA, USA, “the foundation”) for the integrated discovery and…
Read More...

SAB Biotherapeutics, a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies…
Read More...

Pre-Filled Syringes and Injectable Drug Devices Industry Survey Pre-Filled Syringes and Injectable Drug Devices 2021/2022 International State of the Industry Survey In…
Read More...

BioMarin Pharmaceutical Inc. and Skyline Therapeutics (formerly Geneception), a gene and cell therapy company focused on developing novel treatments for unmet medical needs, announced a…
Read More...

Valneva SE a specialty vaccine company, today announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.…
Read More...

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced the launch of the NAV3-33 Phase 3 clinical…
Read More...

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued advice on the use of PAXLOVID (nirmatrelvir tablets…
Read More...

Alpine Immune Sciences, Inc. and Horizon Therapeutics plc announced an exclusive license and collaboration agreement for the development and commercialization of up to four preclinical…
Read More...

SMi Presents the 16th Annual Conference: Parallel Trade 2022 Conference Date: 21st – 22nd  March 2022 Workshop date: 23rd March 2022 Website:  www.parallel-trade.com/ Navigating…
Read More...